NCT00887770 - A Study to Investigate the Potential for AZD5672 to Affect the Electrical Conduction Pathways in the Heart | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2009

Study Completion Date

July 31, 2009

Conditions

Rheumatoid Arthritis

Interventions

DRUG

AZD5672

12 x 50mg tablet, oral, single dose

DRUG

Moxifloxacin

1 x 400mg capsule, oral, single dose

DRUG

placebo

12 x matched to AZD5672 50 mg tablet

DRUG

AZD5672

3 x 50mg tablet, oral. single dose

DRUG

placebo

9 x matched to AZD5672 50mg tablet

DRUG

placebo

1 x matched to Moxifloxacin capsule

Trial Locations (1)

Research Site, London